Literature DB >> 1549955

Transforming growth factor beta 1 stimulates type II collagen expression in cultured periosteum-derived cells.

T Izumi1, S P Scully, A Heydemann, M E Bolander.   

Abstract

Chondrogenesis can occur during a bone repair process, which is related to several growth factors. Transforming growth factor beta 1 (TGF-beta 1) downregulates the expression of type II collagen by chondrocytes in vitro, but injection of TGF-beta 1 into the periosteum in vivo increases type II collagen mRNA levels and initiates chondrogenesis. We examined the effect of TGF-beta 1 on collagen gene expression in a bovine periosteum-derived cell culture system to evaluate its direct effect on the periosteum. Cultured cells expressed alkaline phosphatase and collagen pro alpha 1(I) and pro alpha 1(II) mRNAs. A low level of type II collagen synthesis was demonstrated by immunoprecipitation. TGF-beta 1 had no effect on periosteal cell proliferation. Expression of collagen pro alpha 1(I) mRNA did not change with TGF-beta 1 treatment, but alkaline phosphatase mRNA showed a dose-dependent decrease. Expression of collagen pro alpha 1(II) mRNA was stimulated 2.7-fold by TGF-beta 1. TGF-beta 1 also caused a 2.6-fold increase in type II collagen synthesis by immunoprecipitation. These findings indicate that TGF-beta 1 is an enhancer of the expression of the chondrocyte phenotype of the periosteal cells and suggest that TGF-beta 1 is important in initiating and promoting cartilage formation in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549955     DOI: 10.1002/jbmr.5650070116

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  Transforming growth factor beta one (TGF-beta 1) enhancement of the chondrocytic phenotype in aged perichondrial cells: an in vitro study.

Authors:  M C Lee; R S Goomer; K Takahashi; F L Harwood; M Amiel; D Amiel
Journal:  Iowa Orthop J       Date:  2000

Review 2.  Mechanical modulation of osteochondroprogenitor cell fate.

Authors:  Melissa L Knothe Tate; Thomas D Falls; Sarah H McBride; Radhika Atit; Ulf R Knothe
Journal:  Int J Biochem Cell Biol       Date:  2008-05-24       Impact factor: 5.085

Review 3.  Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells.

Authors:  Hana Chang; Melissa L Knothe Tate
Journal:  Stem Cells Transl Med       Date:  2012-05-30       Impact factor: 6.940

4.  Human periosteum-derived stem cells for tissue engineering applications: the role of VEGF.

Authors:  C Ferretti; V Borsari; M Falconi; A Gigante; R Lazzarini; M Fini; R Di Primio; M Mattioli-Belmonte
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

5.  Transforming growth factor-beta inhibition of mineralization by neonatal rat osteoblasts in monolayer and collagen gel culture.

Authors:  D J Talley-Ronsholdt; E Lajiness; K Nagodawithana
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-04       Impact factor: 2.416

6.  Immunohistochemical analysis of transforming growth factor beta isoforms and their receptors in human cartilage from normal and osteoarthritic femoral heads.

Authors:  M-P Verdier; S Seité; K Guntzer; J-P Pujol; K Boumédiène
Journal:  Rheumatol Int       Date:  2003-11-14       Impact factor: 2.631

7.  Isolation and Osteogenic Differentiation of Rat Periosteum-derived Cells.

Authors:  Heidi Andrea Declercq; Leo Isabelle De Ridder; Maria Jozefa Cornelissen
Journal:  Cytotechnology       Date:  2005-09       Impact factor: 2.058

8.  Rhinosurgery in children: developmental and surgical aspects of the growing nose.

Authors:  Carel D A Verwoerd; Henriette L Verwoerd-Verhoef
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27

9.  Reduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacity.

Authors:  E N Blaney Davidson; A Scharstuhl; E L Vitters; P M van der Kraan; W B van den Berg
Journal:  Arthritis Res Ther       Date:  2005-09-30       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.